Role of Bone-Type Tissue-Nonspecific Alkaline Phosphatase and PHOSPO1 in Vascular Calcification

被引:38
作者
Bobryshev, Yuri V. [1 ]
Orekhov, Alexander N. [2 ,3 ]
Sobenin, Igor [3 ,4 ]
Chistiakov, Dimitry A. [5 ]
机构
[1] Univ New S Wales, Sch Med Sci, Fac Med, Kensington, NSW 2052, Australia
[2] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow 143025, Russia
[3] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Cellular Mech Atherogenesis, Moscow 125315, Russia
[4] Russian Cardiol Res & Prod Complex, Med Genet Lab, Moscow 121552, Russia
[5] Pirogov Russian State Med Univ, Dept Med Nanobiotechnol, Moscow 117997, Russia
关键词
Arterial calcification; atherosclerosis; vascular smooth muscle cells; mineralizing matrix vesicles; bone-type tissue-nonspecific alkaline phosphatise; PHOSPO1; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR PYROPHOSPHATE METABOLISM; NECROSIS-FACTOR-ALPHA; MATRIX VESICLES; GROWTH-PLATE; ARTERIAL CALCIFICATION; OSTEOGENIC DIFFERENTIATION; ATHEROSCLEROTIC ARTERIES; SKELETAL MINERALIZATION; INORGANIC PYROPHOSPHATE;
D O I
10.2174/1381612820666140212193011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Matrix vesicle (MV)-mediated mineralization is important for bone ossification. However, under certain circumstances such as atherosclerosis, mineralization may occur in the arterial wall. Bone-type tissue-nonspecific alkaline phosphatase (TNAP) hydrolyzes inorganic pyrophosphate (PPi) and generates inorganic phosphate (Pi), which is essential for MV-mediated hydroxyapatite formation. MVs contain another phosphatase, PHOSPHO1, that serves as an additional supplier of Pi. Activation of bone-type tissue-nonspecific alkaline phosphatase (TNAP) in vascular smooth muscle cells precedes vascular calcification. By degrading PPi, TNAP plays a procalcific role changing the Pi/PPi ratio toward mineralization. A pathologic role of bone-type TNAP and PHOSPHO1 make them to be attractive targets for cardiovascular therapy.
引用
收藏
页码:5821 / 5828
页数:8
相关论文
共 92 条
[1]   Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity [J].
Addison, William N. ;
Azari, Fereshteh ;
Sorensen, Esben S. ;
Kaartinen, Mari T. ;
McKee, Marc D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (21) :15872-15883
[2]   Expression of cartilage-specific markers in calcified and non-calcified atherosclerotic lesions [J].
Aigner, Thomas ;
Neureiter, Daniel ;
Campean, Valentina ;
Soder, Stephan ;
Amann, Kerstin .
ATHEROSCLEROSIS, 2008, 196 (01) :37-41
[3]   Aortic Msx2-Wnt calcification cascade is regulated by TNF-α-Dependent signals in diabetic Ldlr-/- mice [J].
Al-Aly, Ziyad ;
Shao, Jian-Su ;
Lai, Chung-Fang ;
Huang, Emily ;
Cai, Jun ;
Behrmann, Abraham ;
Cheng, Su-Li ;
Towler, Dwight A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (12) :2589-2596
[4]   Matrix vesicles and calcification. [J].
H. Clarke Anderson .
Current Rheumatology Reports, 2003, 5 (3) :222-226
[5]   The role of matrix vesicles in growth plate development and biomineralization [J].
Anderson, HC ;
Garimella, R ;
Tague, SE .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :822-837
[6]  
ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
[7]   Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture [J].
Bobryshev, Y. V. ;
Killingsworth, M. C. ;
Lord, R. S. A. ;
Grabs, A. J. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (5B) :2073-2082
[8]   Spatial distribution of osteoblast-specific transcription factor Cbfa1 and bone formation in atherosclerotic arteries [J].
Bobryshev, Yuri V. ;
Killingsworth, Murray C. ;
Lord, Reginald S. A. .
CELL AND TISSUE RESEARCH, 2008, 333 (02) :225-235
[9]   Are calcifying matrix vesicles in atherosclerotic lesions of cellular origin? [J].
Bobryshev, Yuri V. ;
Killingsworth, Murray C. ;
Huynh, Thuan G. ;
Lord, Reginald S. A. ;
Grabs, Anthony J. ;
Valenzuela, Stella M. .
BASIC RESEARCH IN CARDIOLOGY, 2007, 102 (02) :133-143
[10]   CALCIFIED DEPOSIT FORMATION IN INTIMAL THICKENINGS OF THE HUMAN AORTA [J].
BOBRYSHEV, YV ;
LORD, RSA ;
WARREN, BA .
ATHEROSCLEROSIS, 1995, 118 (01) :9-21